Two more COVID-19 vaccines approved under EUA
India approved two more vaccines, Corbevax and Covovax, against COVID-19 under emergency use authorization (EUA). These vaccines got approval for administration to adults aged above 18 years. Mansukh Mandaviya, the Union Minister for Health & Family Welfare, tweeted on this matter yesterday.
Corbevax is manufactured by Hyderabad-based Biological-E. It is a protein subunit vaccine. The vaccine is co-developed by Biological E, Baylor College of Medicine in Houston, and Dynavax Technologies, USA.
Covovax is manufactured by Serum Institute of India, Pune under licence from Novavax, a US-based company. It is a nanoparticle-based vaccine.
World Health Organisation (WHO) approved Covovax under Emergency Use Listing to ensure more people across the globe get vaccinated. The vaccine is available as part of the COVAX facility.
Currently, Covishield, Covaxin and Sputnik V are used in India’s vaccination programme. There is no update on the inclusion of Corbevax and Covovax vaccines in the country’s vaccination drive.
Recently, the Food and Drugs Administration (FDA) approved Molnupiravir for the treatment of COVID-19 patients with mild and moderate symptoms. The drug showed promising results in clinical trials. Besides, the administration of the drug is easy as it can be consumed as a pill.
In this context, thirteen companies in the country get readied to manufacture the drug. This drug has been approved under EUA to treat COVID-19 patients who have a risk of progression.
The FDA, in its recent statement, said that Molnupiravir is effective in treating COVID-19. However, extra caution shall be taken while prescribing the drug. It shall be prescribed only to certain adults where it is clinically appropriate.
The drug should not be used as preventive medicine. FDA approved Paxlovid manufactured by Pfizer Inc. under EUA. However, the drug is yet to get approval in India.
Meanwhile, Cipla is planning to launch Molnupiravir under the brand name Cipmolnu.
Image by ulleo from Pixabay (Free for commercial use)
You may also like
Image Reference: https://pixabay.com/photos/ampoules-vaccination-vaccine-2045833/
Recent Posts
- How dried flowers are reviving rural enterprise in ManipurDianthe now records an annual turnover of about ₹12 lakh and supports nearly 200 cultivators.
- India tightens LPG booking rules amid energy supply assuranceThe government has extended the minimum waiting period for booking domestic LPG cylinders from 21 to 25 days.
- Karnataka proposes social media ban for under-16sKarnataka CM Siddaramaiah announced that Karnataka plans to ban social media access for children below 16, citing concerns about addiction and harmful online content. However, mental health experts and educators have warned that a strict restriction may not effectively address the deeper challenges of digital exposure.
- How dried flowers are reviving rural enterprise in Manipur
What’s new at WeRIndia.com
News from 700+ sources
-
Exterior Home Painting 101: Everything Beginners Should Know
-
Japan to Release Oil Reserves as Early as Monday: Takaichi
-
School assembly news headlines for March 12: Top national, international, business, sports update and thought of the day
-
G7 Inches Closer To Tapping Oil Reserves To Tackle Price Rise
-
Gambhir Dismisses Criticism That Indian Wickets Are ‘Tailored’ To Suit Home Team
-
Over 93,000 posts vacant in CAPFs: govt. tells Rajya Sabha
-
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..








Leave a Reply